American Well Corporation Class A (AMWL)

Over the past six months, American Well Corp. has experienced several events impacting its stock price. In Q3 2025, Amwell reported revenue of $56.3 million, an 8% decrease year-over-year, with subscription revenue increasing by 18%. In Q2 2025, Amwell reported revenue of $70.9 million, exceeding analyst expectations. Amwell divested its virtual psychiatric care business to Avel eCare. The share price as of January 9, 2026, was $5.17, representing a decline of 28.39% from $7.22 on January 10, 2025. Insider sentiment is negative due to open-market selling from key executives. Analysts have maintained "Equal-Weight" and "Overweight" recommendations, with an average rating of "Hold" and a 12-month stock price target of $7.58.

There is no explicit information detailing the demand seasonality for American Well Corp.'s products and services. However, the company's Q1 2025 earnings call summary noted that overall revenue was slightly lower compared to Q4 2024 due to a "seasonal decrease in care point revenues," suggesting some level of seasonality in certain product lines. The company's strategy to focus on subscription-heavy offerings is intended to make it "less susceptible to visit fluctuations," which could imply that visit volumes might have some seasonal variations.

American Well Corporation (Amwell) is a telemedicine company providing a SaaS platform for technology-enabled healthcare, acting as a digital infrastructure backbone for virtual and hybrid care. Amwell's major products and services include the Converge Platform, Amwell Medical Group (AMG) Services, Carepoint Devices, Specialty Care Programs, and Professional Services. The company is shifting towards a higher-margin, subscription-based SaaS model.

American Well Corporation delivers digitally enabling hybrid care in the United States and internationally. The company operates in all 50 U.S. states and works with numerous health plans and health systems across the nation. Internationally, Amwell has a presence through partnerships and offices in locations such as Dublin, Ireland, and Ramat Gan, Israel. Its platform is designed to comply with regional privacy and data security regulations, including HIPAA in the U.S. and GDPR in Europe.

Amwell's brand reputation is centered on its mission to transform healthcare delivery by making it more accessible, affordable, and higher quality. The company emphasizes its role as a technology-enabled care platform focused on advancing telehealth interoperability, user experience, and clinical quality. Amwell highlights its commitment to reliable execution and partnership with providers, payers, and innovators to create a connected ecosystem of care. No specific events negatively impacted American Well Corp.'s brand reputation in the past year.

American Well Corporation's ownership structure includes a significant blend of institutional and insider capital. Major institutional shareholders include Senvest Management, LLC, Morgan Stanley, Vanguard Group Inc, Caledonia (Private) Investments Pty Ltd, BlackRock, Inc., Rock Point Advisors, LLC, Acadian Asset Management Llc, and Renaissance Technologies Llc. Insiders hold a significant majority of the company's shares, indicating their strong influence on strategic direction.